Page last updated: 2024-10-23

aztreonam and Critical Illness

aztreonam has been researched along with Critical Illness in 2 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Critical Illness: A disease or state in which death is possible or imminent.

Research Excerpts

ExcerptRelevanceReference
" All patients had received at least two aztreonam doses before the dosage interval being studied."1.30Pharmacokinetics of aztreonam in critically ill surgical patients. ( Asensio, J; Belzberg, H; Berne, TV; Cornwell, EE; Demetriades, D; Gill, MA; Kern, JW; Theodorou, D; Yu, W, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornwell, EE1
Belzberg, H1
Berne, TV1
Gill, MA1
Theodorou, D1
Kern, JW1
Yu, W1
Asensio, J1
Demetriades, D1
Boucher, BA1

Reviews

1 review available for aztreonam and Critical Illness

ArticleYear
Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient.
    American journal of surgery, 2000, Volume: 179, Issue:2A Suppl

    Topics: Aztreonam; Cost-Benefit Analysis; Critical Illness; Cross Infection; Drug Costs; Humans; Monobactams

2000

Other Studies

1 other study available for aztreonam and Critical Illness

ArticleYear
Pharmacokinetics of aztreonam in critically ill surgical patients.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Mar-01, Volume: 54, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Critical Illness; Female; Gram-Negative Bacte

1997